Mirabegron

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 70518-4304
  • Package NDC 70518-4304-0
  • Application number ANDA209488
  • SPL ID 5a9956d6-df8d-d72e-e063-6394a90a2126
  • SPL set ID 5f7a1758-8691-4e53-96d6-a01626ee8140
  • UNII MVR3JL3B2V
  • RxCUI 1300801

What the source publishes

Labeler
REMEDYREPACK INC.
Active ingredients
Mirabegron
Form
TABLET, EXTENDED RELEASE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:70518-4304_5a9956d6-df8d-d72e-e063-6394a90a2126
{
  "name": "Mirabegron",
  "splId": "5a9956d6-df8d-d72e-e063-6394a90a2126",
  "labels": [
    {
      "setId": "5f7a1758-8691-4e53-96d6-a01626ee8140",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5f7a1758-8691-4e53-96d6-a01626ee8140",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5f7a1758-8691-4e53-96d6-a01626ee8140"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "REMEDYREPACK INC.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-4304-0)",
      "package_ndc": "70518-4304-0",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250307"
    }
  ],
  "productId": "70518-4304_5a9956d6-df8d-d72e-e063-6394a90a2126",
  "useDomain": "unknown",
  "dosageForm": "TABLET, EXTENDED RELEASE",
  "productNdc": "70518-4304",
  "deaSchedule": null,
  "genericName": "Mirabegron",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "MIRABEGRON",
      "strength": "50 mg/1"
    }
  ],
  "applicationNumber": "ANDA209488",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20250307",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000185008",
      "N0000185007",
      "N0000182137",
      "N0000190114",
      "N0000185503"
    ],
    "unii": [
      "MVR3JL3B2V"
    ],
    "rxcui": [
      "1300801"
    ],
    "spl_set_id": [
      "5f7a1758-8691-4e53-96d6-a01626ee8140"
    ],
    "pharm_class_epc": [
      "beta3-Adrenergic Agonist [EPC]"
    ],
    "pharm_class_moa": [
      "Adrenergic beta3-Agonists [MoA]",
      "Cytochrome P450 2D6 Inhibitors [MoA]",
      "Cytochrome P450 3A Inhibitors [MoA]",
      "P-Glycoprotein Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "REMEDYREPACK INC."
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:70518-4304_5a9956d6-df8d-d72e-e063-6394a90a2126"